Track this tender and download its BOQ

Free account: deadline alerts, clause analysis and bidder data.

Official Portal
Kem Hospital Parel / Maharashtra Medicines MaharashtraAOC Awarded

Inj.Hemlibra (Emicizumab 60mg/1ml)

Estimated Value

₹20.00 Lakh

Item Rate
EMD Guarantee

₹40,000

Fixed
Tender Fee

₹3,894

Payable
Work Period

30 Days

Awarded: SURYAA HEALTHCARE 20 Feb 2025
BiddingTech OpeningFinancial OpeningAOC Award

Contractor Tender Intelligence

Pro Feature

Unlock should you bid, how much to bid, and who will bid.

Upgrade to Pro

Tender Details

ID: 2025_MCGM_1137369_1 Item Rate

Work Description

Description
Inj.Hemlibra (Emicizumab 60mg/1ml)

Key dates

Published16 Jan 2026
Bid due20 Feb 2025, 03:00 pm
Bid opening05 Mar 2025
Documents until20 Feb 2025

Bidders & evaluation

Pipeline: AOC Awarded
✓ 1. e-Publishing

16 Jan 2026

✓ 2. Bid Submission

Closed 20 Feb 2025, 03:00 pm

✓ 3. Tech Opening

1 bids recorded • 1 qualified

✓ 4. Financial Opening

1 ranked • L1 ranked

✓5. Award (AOC)

SURYAA HEALTHCARE

Financial Evaluation & L1 Contractor Ranking

1 Bidder(s) Ranked
RankContractor / Firm NameQuoted Bid (₹)Variance vs EstimatePortal StatusCommittee RemarksAction
L1SURYAA HEALTHCARE↗
Bid ID: 6438556•Submitted: 21-Jan-2025 11:48 AM
₹19.15 Lakhs -4.23% ₹-84,601.76 Accepted-AOC L1 Bidder Profile ↗

Technical Cover Scrutiny Results (1)

Checked by the department's scrutiny committee

#Bid IDContractor NameSubmitted DateTechnical StatusDisqualification / RemarksPortal StatusProfile
1 6438556 SURYAA HEALTHCARE 21-Jan-2025 11:48 AM ✓ QUALIFIED L1 Bidder Accepted-AOC Dossier ↗

Documents & BOQ

Members Only
Member Feature • Free Registration

Tender Documents & Itemised BOQ Protected

Sign in free to download the notice, bidding documents and BOQ.

✓Original BOQ (.xls)
✓Official NIT & SBD
✓Extracted Criteria

Location

Open in Maps
Kem Hospital Parel 400012